AIM ImmunoTech AIM Balance Sheet (2010-2026)

NYSE AIM
$0.18 +0.01 (+3.40%)
As of: Sep 30, 2026 · 10:12 AM EDT
Reported Financials

AIM ImmunoTech Quarterly Balance Sheet

Periods 65 quarters
Latest Jun 2026

AIM ImmunoTech reported total assets of $12.73M and total liabilities of $4.99M for the quarter ended Jun 2026, up 208.3% year over year. This balance sheet covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
37.35M32.09M28.99M34.45M29.76M27.05M23.39M21.04M15.26M5.44M3.29M3.55M0.92M1.70M0.90M0.48M2.35M2.98M5.82M9.90M
Short-term InvestmentsInvestments (Current)
16.18M7.32M6.99M7.14M7.45M7.36M7.17M7.63M7.65M6.51M6.29M2.28M1.35M0.36M0.06M0.06M0.06M0.06M
Cash & Current Investments
37.35M48.27M28.99M41.77M36.74M34.19M30.85M28.40M22.43M13.07M10.94M10.06M7.20M3.98M2.25M0.83M2.41M3.05M5.88M9.96M
Receivables - NetNet Receivables
0.03M1.68M1.76M0.03M0.05M1.18M0.01M
Receivables - OtherOther Receivables
1.64M1.64M1.68M0.02M
Receivables
0.03M3.35M1.76M0.03M0.05M1.18M0.01M
Work In Process
Prepaid Assets
0.16M0.30M0.30M0.37M0.81M0.46M0.55M0.44M0.26M0.30M0.36M0.30M0.37M0.20M0.32M0.19M0.17M0.24M0.34M0.47M
Current Assets
38.04M50.21M50.38M46.05M41.15M36.32M33.16M28.87M22.74M14.56M11.31M10.36M7.57M4.18M2.58M1.02M2.58M3.29M6.21M10.43M
Non-Current Assets
Construction in Progress
Land & Improvements
10.53M3.90M
Property, Plant & Equipment (Net)PP&E (Net)
5.99M4.05M0.14M0.13M0.12M0.20M0.15M0.14M0.14M0.13M0.12M0.11M0.12M0.11M0.10M0.09M0.08M0.07M0.06M0.05M
Long-Term Investments
15.81M
Intangibles
1.84M1.97M1.99M2.01M2.01M1.94M2.04M2.15M2.31M2.31M2.49M2.53M2.59M2.27M2.17M2.04M1.66M1.66M1.71M
Goodwill & Intangibles
1.84M1.97M1.99M2.01M2.01M1.94M2.04M2.15M2.31M2.31M2.49M2.53M2.59M2.27M2.17M2.04M1.66M1.66M1.71M
Other Non-Current Assets
1.25M1.32M1.51M1.81M2.14M1.20M1.46M1.78M2.10M1.69M1.69M2.05M2.72M1.11M0.74M0.35M0.36M0.38M0.33M0.27M
Non-Current Assets
25.04M7.49M3.77M4.84M5.13M4.17M4.30M4.75M5.12M4.83M4.88M5.35M6.02M4.43M3.66M3.10M2.92M2.49M2.37M2.30M
Assets
63.08M57.70M54.16M50.88M46.28M40.49M37.46M33.62M27.86M19.38M16.19M15.71M13.59M8.61M6.25M4.13M5.49M5.78M8.59M12.73M
Liabilities
Current Liabilities
Accounts Payables
0.37M0.20M0.38M0.71M0.96M0.38M0.96M2.15M2.79M6.44M6.57M5.46M6.26M6.38M6.94M7.30M1.25M1.63M1.22M0.48M
Notes Payables
1.62M2.35M2.59M2.31M1.95M2.29M1.88M3.55M4.00M3.62M
Payables
0.37M0.20M0.38M0.71M0.96M0.38M0.96M2.15M2.79M6.44M8.19M7.81M8.86M8.69M8.89M9.59M3.13M5.18M5.22M4.10M
Accumulated Expenses
0.36M0.44M0.33M0.50M1.77M0.81M0.70M0.53M1.72M1.99M1.45M0.80M1.01M0.61M0.64M0.57M0.68M0.80M0.67M0.59M
Other Accumulated Expenses
0.18M0.21M0.16M0.13M0.20M0.20M0.09M0.08M0.11M0.04M0.01M0.12M0.05M0.03M0.05M0.11M0.07M0.19M0.07M0.07M
Short term Debt
Current Leases
Total Current Liabilities
0.77M0.67M0.77M1.37M2.90M1.36M1.84M2.88M4.72M8.65M9.88M8.84M10.10M9.54M9.77M10.39M4.04M6.22M6.14M4.95M
Non-Current Liabilities
Capital Leases
Non-Current Debt
0.95M0.28M0.14M
Convertible Debt
Operating Leases
0.11M0.11M0.08M0.73M0.69M0.66M0.64M0.60M0.54M0.49M0.54M0.49M0.44M0.40M0.34M0.28M0.23M0.17M0.10M0.04M
Other Non-Current Liabilities
0.16M0.04M0.00M0.00M7.30M8.24M
Total Non-Current Liabilities
0.88M0.79M0.85M2.10M4.27M7.32M
Total Liabilities
1.03M0.82M0.85M2.10M3.59M2.02M2.47M3.48M5.26M9.15M11.36M9.61M10.68M9.93M10.11M10.68M11.57M15.56M6.46M4.99M
Shareholder's Equity
Total Debt
2.57M2.64M2.73M2.31M1.95M2.29M1.88M3.55M4.00M3.62M
Common Equity
62.05M56.88M53.30M48.78M42.70M38.47M34.99M30.14M22.60M10.23M4.83M6.10M2.91M-1.32M-3.86M-6.55M-6.08M-9.78M2.12M7.74M
Liabilities and Shareholders Equity
63.08M57.70M54.16M50.88M46.28M40.49M37.46M33.62M27.86M19.38M16.19M15.71M13.59M8.61M6.25M4.13M5.49M5.78M8.59M12.73M
Retained Earnings
-355.25M-361.10M-364.92M-369.77M-376.16M-380.55M-384.21M-389.12M-396.93M-409.51M-415.32M-417.16M-420.86M-426.83M-430.53M-433.33M-436.61M-440.79M-443.81M-447.60M
Preferred Shares
0.72M0.71M0.71M0.71M0.71M0.70M0.69M0.69M0.69M0.69M0.69M

AIM ImmunoTech Balance Sheet API

Pull AIM ImmunoTech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AIM&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY